GVK Bio ties up with Endo Pharma

Our Bureau Hyderabad | Updated on January 28, 2013 Published on January 28, 2013

GVK Biosciences has entered into a collaboration agreement with the US-based Endo Pharmaceuticals for discovering novel small molecules targeting a protein.

Under this agreement GVK Bio will use its discovery expertise to deliver a clinical candidate and Endo will develop and commercialise the product arising out of this collaboration.

The Hyderabad-based company recently launched a new initiative called Early Discovery Assets. The early stage asset portfolio is focussed around pain and inflammation. It is about building a set of project assets for potential early stage partnerships.

  Manni Kantipudi, CEO of the company said, "The partnership with Endo is a continuation to build  discovery pipeline through external collaborations."



Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on January 28, 2013
This article is closed for comments.
Please Email the Editor